BioNexus Gene Lab Corp. (BGLC)
OTCMKTS: BGLC · Delayed Price · USD
0.582
-0.030 (-4.82%)
Apr 23, 2024, 4:00 PM EDT - Market closed

BioNexus Gene Lab Statistics

Total Valuation

BGLC has a market cap or net worth of $10.36 million. The enterprise value is $1.25 million.

Market Cap 10.36M
Enterprise Value 1.25M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

BGLC has 17.79 million shares outstanding. The number of shares has increased by 22.04% in one year.

Shares Outstanding 17.79M
Shares Change (YoY) +22.04%
Shares Change (QoQ) +5.33%
Owned by Insiders (%) 64.38%
Owned by Institutions (%) 0.59%
Float 9.96M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.06
Forward PS n/a
PB Ratio 1.07
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.13
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.01.

Current Ratio 4.93
Quick Ratio 6.26
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -307.22

Financial Efficiency

Return on equity (ROE) is -27.22% and return on invested capital (ROIC) is -26.49%.

Return on Equity (ROE) -27.22%
Return on Assets (ROA) -23.06%
Return on Capital (ROIC) -26.49%
Revenue Per Employee $361,882
Profits Per Employee -$97,372
Employee Count 27
Asset Turnover 1.04
Inventory Turnover 7.98

Taxes

In the past 12 months, BGLC has paid $21,526 in taxes.

Income Tax 21,526
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.42% in the last 52 weeks. The beta is 1.95, so BGLC's price volatility has been higher than the market average.

Beta (1Y) 1.95
52-Week Price Change -84.42%
50-Day Moving Average 0.74
200-Day Moving Average 1.26
Relative Strength Index (RSI) 44.11
Average Volume (30 Days) 1,574,185

Short Selling Information

The latest short interest is 43,358, so 0.24% of the outstanding shares have been sold short.

Short Interest 43,358
Short Previous Month 20,059
Short % of Shares Out 0.24%
Short % of Float 0.44%
Short Ratio (days to cover) 0.15

Income Statement

In the last 12 months, BGLC had revenue of $9.77 million and -$2.63 million in losses. Loss per share was -$0.17.

Revenue 9.77M
Gross Profit 1.33M
Operating Income -2.59M
Pretax Income -2.61M
Net Income -2.63M
EBITDA -2.49M
EBIT -2.59M
Loss Per Share -$0.17
Full Income Statement

Balance Sheet

The company has $5.93 million in cash and $133,395 in debt, giving a net cash position of $9.10 million or $0.51 per share.

Cash & Cash Equivalents 5.93M
Total Debt 133,395
Net Cash 9.10M
Net Cash Per Share $0.51
Equity / Book Value 9.66M
Book Value Per Share 0.54
Working Capital 6.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.30 million and capital expenditures -$149,398, giving a free cash flow of -$1.45 million.

Operating Cash Flow -1.30M
Capital Expenditures -149,398
Free Cash Flow -1.45M
FCF Per Share -$0.08
Full Cash Flow Statement

Margins

Gross margin is 13.61%, with operating and profit margins of -26.54% and -26.91%.

Gross Margin 13.61%
Operating Margin -26.54%
Pretax Margin -26.69%
Profit Margin -26.91%
EBITDA Margin -25.43%
EBIT Margin -26.54%
FCF Margin -14.85%

Dividends & Yields

BGLC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.04%
Shareholder Yield -22.04%
Earnings Yield -25.39%
FCF Yield -14.01%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on July 20, 2023. It was a reverse split with a ratio of 1:12.

Last Split Date Jul 20, 2023
Split Type Reverse
Split Ratio 1:12

Scores

BGLC has an Altman Z-Score of 4.12 and a Piotroski F-Score of 3.

Altman Z-Score 4.12
Piotroski F-Score 3